Nathalie Gaspar,Giun-Yi Hung,Sandra J. Strauss,Quentin Campbell‐Hewson,Filemon S. Dela Cruz,Julia L. Glade Bender,Kyung‐Nam Koh,Sarah Burkhead Whittle,Gcf Chan,Nicolas U. Gerber,Sauli Palmu,Daniel A. Morgenstern,Alessandra Longhi,Fredrik Baecklund,Jun Ah Lee,Franco Locatelli,Catalina Márquez-Vega,Katherine A. Janeway,Geoffrey McCowage,Martin G. McCabe
出处
期刊:JAMA Oncology [American Medical Association] 日期:2024-10-17被引量:1
The combination of ifosfamide and etoposide (IE) is commonly used to treat relapsed or refractory osteosarcoma; however, second-line treatment recommendations vary across guidelines.